Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 282.77 | 5.50 |
PEG Ratio (TTM) | 7.79 | 1.49 |
P/S Ratio (TTM) | 1.07 | 2.45 |
P/B Ratio (TTM) | 2.98 | 2.45 |
P/FCF Ratio (TTM) | N/A | 88.23 |
Price to 5YR AVG Earnings Ratio | N/A | 124.04 |
Price to 5YR AVG FCF Ratio | N/A | -15.98 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.60% | 0.69% |
ROE (TTM) | 1.03% | -2.66% |
Net Profit Margin (TTM) | 0.38% | 2.27% |
ROIC 5YR AVG | N/A | -11.27% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -131.37% | 323.05% | N/A |
Revenue | 2.33% | 44.68% | N/A |
Net Income | -131.01% | 322.10% | N/A |
Cash Flow | -25.00% | 1,377.40% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.35 | 1.32 |
Quick Ratio (TTM) | 1.35 | 1.22 |
D/E Ratio (TTM) | 0.05 | -2.30 |
Interest Coverage (TTM) | 24.59 | -30.78 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 5.06 | 2.15 |
LTL to 5YR AVG FCF | N/A | 23.66 |
Shares Outstanding Growth 5YR AVG | N/A | 4.37% |